Lupinetti F M, Bolling S F, Bove E L, Brunsting L A, Crowley D C, Lynch J P, Orringer M B, Whyte R I, Deeb G M
Department of Surgery, University of Michigan School of Medicine, Ann Arbor.
Ann Thorac Surg. 1994 Jun;57(6):1545-8; discussio 1549. doi: 10.1016/0003-4975(94)90119-8.
Fixed pulmonary hypertension has been a contraindication to correction of congenital heart defects. Beginning in February 1991, we pursued a policy of performing single-lung transplantation with intracardiac repair for selected patients with this physiology, reserving heart-lung transplantation for those with unreconstructable heart disease. Of 7 patients treated under this protocol, 5 underwent single-lung transplantation and intracardiac repair. The cardiac anomalies included complete atrioventricular canal (1), aortopulmonary window (1), atrial septal defect (1), and ventricular septal defect (2). One patient died perioperatively. All 4 patients surviving operation remained alive through the first postoperative year, but 3 died 13, 17, and 22 months after operation. Two other patients with pulmonary hypertension (1 with tricuspid atresia, 1 after failed Mustard procedure) received a heart-lung transplant and are well 15 and 18 months after operation. This experience demonstrates that selected patients with major intracardiac defects and pulmonary hypertension may have good early results after cardiac repair and single-lung transplantation, but that long-term results are considerably less favorable.
固定性肺动脉高压一直是先天性心脏缺陷矫正术的禁忌证。自1991年2月起,我们对具有这种生理状况的特定患者采取了单肺移植联合心内修复的策略,将心肺移植保留给那些患有无法修复的心脏病的患者。按照该方案治疗的7例患者中,5例接受了单肺移植和心内修复。心脏异常包括完全性房室通道(1例)、主肺动脉窗(1例)、房间隔缺损(1例)和室间隔缺损(2例)。1例患者在围手术期死亡。所有4例术后存活的患者在术后第一年都存活下来,但3例分别在术后13、17和22个月死亡。另外2例肺动脉高压患者(1例为三尖瓣闭锁,1例为Mustard手术失败后)接受了心肺移植,术后15个月和18个月情况良好。这一经验表明,患有严重心内缺陷和肺动脉高压的特定患者在心脏修复和单肺移植后可能有良好的早期结果,但长期结果则不太理想。